Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Rakovina Therapeutics Inc (RKV.VN)

Rakovina Therapeutics Inc (RKV.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Junior Biotech Utilizes AI To Shorten Drug Discovery Timelines, Ultimately Saving Lives Yolowire - Tue Sep 10, 2024

The urgent need for innovative technologies to accelerate the development of life-saving %Cancer therapies has never been more critical. With millions of lives and billions of dollars at stake, the potential...

MRK : 121.66 (+0.07%)
NVS : 165.38 (-0.48%)
RHHBY : 59.6900 (-0.68%)
AZN : 208.67 (-0.39%)
BMRN : 61.83 (+3.14%)
KTRA : 0.2154 (-6.31%)
XBIT : 2.41 (+2.99%)
RKV.VN : 0.150 (+3.45%)
Stocks in play: Rakovina Therapeutics Inc. Baystreet - Mon Apr 1, 2024

Will be hosting an informational webinar on Wednesday, April 3. Rakovina Therapeutics Inc. shares V.RKV ...

RKV.VN : 0.150 (+3.45%)
Rakovina Therapeutics Announces Results from Annual General Meeting Globe Newswire - Thu Jun 23, 2022

VANCOUVER, British Columbia, June 23, 2022 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSXV: RKV) (the “Company”), a biopharmaceutical company...

RKV.VN : 0.150 (+3.45%)
Rakovina Therapeutics Inc. Announces Q1 2022 Financial Results and Provides Corporate Update Globe Newswire - Thu May 26, 2022

VANCOUVER, British Columbia, May 26, 2022 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company”), a biopharmaceutical company...

RKV.VN : 0.150 (+3.45%)
Rakovina Therapeutics Inc. Announces 2021 Financial Results and Provides Corporate Update Globe Newswire - Wed Apr 27, 2022

VANCOUVER, British Columbia, April 27, 2022 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company”) a biopharmaceutical company...

RKV.VN : 0.150 (+3.45%)
InvestmentPitch Media Video Discusses Rakovina Therapeutics and its Presentation of Preclinical Data Supporting Potential Broad Anticancer Activity of kt-4000 Series at the American Association of Cancer Research Annual General Meeting Globe Newswire - Thu Apr 14, 2022

VANCOUVER, British Columbia, April 14, 2022 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSXV:RKV), a biopharmaceutical company committed to advancing...

RKV.VN : 0.150 (+3.45%)
Rakovina Therapeutics Presents Preclinical Data Supporting Potential Broad Anticancer Activity of kt-4000 Series at the American Association of Cancer Research (AACR) Annual General Meeting Globe Newswire - Tue Apr 12, 2022

VANCOUVER, British Columbia, April 12, 2022 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (“the Company”), a biopharmaceutical company...

RKV.VN : 0.150 (+3.45%)
Rakovina Therapeutics to Present Abstract at the 2022 AACR Special Conference – Sarcomas Globe Newswire - Wed Mar 30, 2022

Company will highlight new data with kt-3000 lead candidates as a potential treatment for Ewing sarcoma...

RKV.VN : 0.150 (+3.45%)
Rakovina Therapeutics to Present Abstract at the 2022 Annual Meeting of the American Association of Cancer Research (AACR) Globe Newswire - Wed Mar 9, 2022

VANCOUVER, British Columbia, March 09, 2022 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (“the Company”), a biopharmaceutical company...

RKV.VN : 0.150 (+3.45%)
The Power Play by The Market Herald Releases New Interviews with Nextech AR, i-80 Gold, Kidoz Inc., Rakovina Therapeutics, Prophecy DeFi, and Saturn Oil & Gas Discussing Their Latest Press Releases ACCESS Newswire - Tue Nov 16, 2021

VANCOUVER, BC / ACCESSWIRE / November 16, 2021 / The Power Play by The Market Herald has announced the release of new interviews with Nextech AR, i-80 Gold, Kidoz Inc., Rakovina Therapeutics, Prophecy...

IAU.TO : 2.63 (+2.33%)
NTAR.CN : 0.1500 (-3.23%)
PDFI.CN : 0.3800 (+8.57%)
SOIL.VN : 2.270 (+3.18%)
KIDZ.VN : 0.360 (+2.86%)
RKV.VN : 0.150 (+3.45%)

Barchart Exclusives

Is This Dividend Stock a Buy Now After Falling Over 11% from Its 2026 Highs? Barchart - Wed Feb 18, 6:30PM CST
Citigroup shares are down 11% from their 2026 highs. The stock has a healthy dividend yield of 2.1% and looks like a good buy after the correction. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot